Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Novel DLL1-Anti-CD19 Chimeric Protein Effectively Targets Notch Activation to B-Cell Acute Lymphoblastic Leukemia and Induces Cell Death

Rebecca E Wiersma, Sankaranarayanan Kannan, PhD, Srinivas S. Somanchi, PhD, Lizhi Zeng, Patrick A. Zweidler-McKay, MDPhD

Blood (2015) 126 (23): 4833.

https://doi.org/10.1182/blood.V126.23.4833.4833

Published: 2015

Journal Articles

A Novel Notch/NRF2 Mechanism Mediates Reductive Stress in Acute Myeloblastic Leukemia (AML): A Therapeutic Strategy to Overcome Chemoresistance

Sankaranarayanan Kannan, PhD, Patrick A. Zweidler-McKay, MDPhD

Blood (2015) 126 (23): 4834.

https://doi.org/10.1182/blood.V126.23.4834.4834

Published: 2015

Journal Articles

Notch Signaling In B-ALL Reveals PLK1 As A Potential Therapeutic Target In B-ALL: PLK1-Selective Inhibitor Poloxin Modulates Cyclin B and P53 Pathways, Leading To Growth Arrest and Apoptosis

Sankaranarayanan Kannan, PhD, Mandy A Hall, PhD, Leonard S Golfman, PhD, Patrick A Zweidler-McKay, MD, PhD

Blood (2013) 122 (21): 2912.

https://doi.org/10.1182/blood.V122.21.2912.2912

Published: 2013

Journal Articles

Notch/HES1 Signaling Stabilizes p53 Expression Via a Novel PARP1-Chfr-PLK1-Mediated Mechanism in B-ALL

Sankaranarayanan Kannan, PhD, Patrick A Zweidler-McKay, MD, PhD

Blood (2012) 120 (21): 1292.

https://doi.org/10.1182/blood.V120.21.1292.1292

Published: 2012

Journal Articles

Notch/HES1 Implicated As a Tumor Suppressor Mechanism in Human AML in Vivo

Leonard S Golfman, PhD, Sankaranarayanan Kannan, PhD, Mandy A Hall, PhD, Patrick A Zweidler-McKay, MD, PhD

Blood (2012) 120 (21): 3524.

https://doi.org/10.1182/blood.V120.21.3524.3524

Published: 2012

Journal Articles

Multiple Mechanisms of Notch-Mediated B-ALL Growth Arrest Via HES1 and PLK1: KIF11, CyclinB and p53

Sankaranarayanan Kannan, PhD, Wendy Fang, MD, Patrick Zweidler-McKay, MD, PhD

Blood (2010) 116 (21): 3137.

https://doi.org/10.1182/blood.V116.21.3137.3137

Published: 2010

Journal Articles

Cell Specific Consequences of Notch Signaling: PARP1/HES1 Interaction Reveals a Novel Tumor Suppressor Mechanism.

Sankaranarayanan Kannan, PhD, Patrick A. Zweidler-McKay, MD, PhD

Blood (2009) 114 (22): 2388.

https://doi.org/10.1182/blood.V114.22.2388.2388

Published: 2009

Journal Articles

Understanding the Role of TRKA Receptor in Acute Myeloid Leukemias: From Proliferation and Pro-Survival Signals to a Novel Therapeutic Approach

Maurizio L Ghisoli, MD, Wendy Fang, MD, Timothy C Graham, BS, Alejandro G Levy, MD, Lizhi Zeng, MD, Sankaranarayanan Kannan, PhD, Riitta M Nolo, PhD, Christine Pien, PhD, Jeffrey L Brown, PhD, Patrick A Zweidler-McKay, MD, PhD

Blood (2008) 112 (11): 3789.

https://doi.org/10.1182/blood.V112.11.3789.3789

Published: 2008

NARROW

A Novel DLL1-Anti-CD19 Chimeric Protein Effectively Targets Notch Activation to B-Cell Acute Lymphoblastic Leukemia and Induces Cell Death

A Novel Notch/NRF2 Mechanism Mediates Reductive Stress in Acute Myeloblastic Leukemia (AML): A Therapeutic Strategy to Overcome Chemoresistance

Notch Signaling In B-ALL Reveals PLK1 As A Potential Therapeutic Target In B-ALL: PLK1-Selective Inhibitor Poloxin Modulates Cyclin B and P53 Pathways, Leading To Growth Arrest and Apoptosis

Notch/HES1 Signaling Stabilizes p53 Expression Via a Novel PARP1-Chfr-PLK1-Mediated Mechanism in B-ALL

Notch/HES1 Implicated As a Tumor Suppressor Mechanism in Human AML in Vivo

Multiple Mechanisms of Notch-Mediated B-ALL Growth Arrest Via HES1 and PLK1: KIF11, CyclinB and p53

Cell Specific Consequences of Notch Signaling: PARP1/HES1 Interaction Reveals a Novel Tumor Suppressor Mechanism.

Understanding the Role of TRKA Receptor in Acute Myeloid Leukemias: From Proliferation and Pro-Survival Signals to a Novel Therapeutic Approach

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only